Expiratory Flow Limitation at Different Exercise Intensities in Coronary Artery Disease

Table 1

Age, anthropometry, risk factors, and medications of all groups.

	RMI (n = 8)	LMI (n = 12)	CAD (n = 9)	CG (n = 12)
Age, years	50.9 ± 5.5	54.7 ± 6.7	58.0 ± 4.4	51.8 ± 7.9
Anthropometry
Height, m	1.68 ± 0.06	1.70 ± 0.08	1.69 ± 0.06	1.72 ± 0.05
Weight, kg	78.6 ± 10.2	83.4 ± 15.0	78.8 ± 10.0	76.5 ± 7.0
Body mass index, kg/m^2	28.0 ± 4.3	28.7 ± 4.5	27.5 ± 2.3	26.0 ± 2.5
Risk factors, n (%)
Past of smoking	1 (12.5)	8 (67)^+	4 (44)	1 (8)
Hypertension	3 (37.5)	8 (67)	4 (44)	0
Dyslipidemia	7 (87.5)	10 (83)	8 (89)	3 (25)
Diabetes	3 (37.5)	5 (42)	2 (22)	0
Family history of CD	8 (100)	9 (75)	9 (100)	10 (83)
Medications, n (%)
Beta-blockers	6 (75)	9 (75)	3 (33)	0
ACE inhibitor	3 (37.5)	8 (67)	2 (22)	0
Diuretic	3 (37.5)	5 (42)	0	0
Hypoglycemic	3 (37.5)	5 (42)	2 (22)	0
Lipid lowering	7 (87.5)	10 (83)	8 (89)	3 (25)
Antiplatelet/anticoagulant	8 (100)	12 (100)	6 (67)	0

Data are presented as mean ± SD or absolute value (percentage) of occurrence. RMI, recent myocardial infarction group; LMI, late myocardial infarction group; CAD, stable coronary artery disease group; CG, control group; n, number of individuals; CD, coronary disease; ACE, angiotensin-converting enzyme. Significant difference in relation to CG. ⁺Significant difference in relation to RMI (). The chi-square test was used.